FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today reported its financial results for the three months ended March 31, 2007. For this quarter, the Company reported a net loss of $5.7 million or $(0.34) per share, compared to a net loss of $3.8 million, or $(2.22) per share, for the same period in 2006. The Company ended the quarter in a strong financial position with $84.2 million of cash, cash equivalents and investments in marketable securities.
